Interleukin-1 Receptor Antagonist Inhibits the Expression of Vascular Endothelial Growth Factor in Colorectal Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|68|2-3|138-145

ISSN： 0030-2414

Source： Oncology, Vol.68, Iss.2-3, 2005-07, pp. : 138-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Significance of Vascular Endothelial Growth Factor C Expression and Angiogenesis at the Deepest Invasive Site of Advanced Colorectal Carcinoma

By  

Oncology, Vol. 62, Iss. 2, 2002-03 ,pp. : 157-166

Karger

Access to resources Recommend Favorite

Expression of Vascular Endothelial Growth Factor D Is Associated with Lymph Node Metastasis in Human Colorectal Carcinoma

By  

Oncology, Vol. 64, Iss. 4, 2003-05 ,pp. : 416-422

Karger

Access to resources Recommend Favorite

Regulation of Insulin-Like Growth Factor-1 Expression in Vascular Endothelial Cells by the Inflammatory Cytokine Interleukin-1

By  

Journal of Vascular Research, Vol. 35, Iss. 3, 1998-06 ,pp. : 143-149

Karger

Access to resources Recommend Favorite

Expression of Vascular Endothelial Growth Factor, Receptor KDR and p53 Protein in Transitional Cell Carcinoma of the Bladder

By  

Urologia Internationalis, Vol. 81, Iss. 1, 2008-07 ,pp. : 72-76

Karger

Access to resources Recommend Favorite

In vitro study of normoxic epidermal growth factor receptor–induced hypoxia‐inducible factor‐1‐alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti–epidermal growth factor receptor therapy

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 8, 2015-08 ,pp. : 1150-1162

John Wiley & Sons Inc

Access to resources Recommend Favorite